As an aducanumab trial participant, Phil Gutis, a reporter with early-stage Alzheimer’s, was part of Aduhelm’s journey to FDA approval. Doctors can soon start…
Image: Phil Gutis receives an aducanumab infusion while carrying out his “silly shoe challenge.” Phil Gutis reflects on the significance of participating in the…
Reflecting on his early-onset Alzheimer’s diagnosis five years on, the author finds inspiration in a friend who was able to put her own illness…
In a surprising turn of events, the Advisory Committee of experts on Biogen’s experimental Alzheimer’s drug aducanumab recommended against FDA approval of the drug…
Slightly more than a year ago now, my sister and I visited a friend from childhood who had been fighting colorectal cancer for more…
Well, I won’t try that again. Last week, I found myself bent over a table, resting my head on pillows as a doctor injected…
Last September, long before COVID-19, quarantines and national lockdowns, I visited a memory care facility in Princeton, New Jersey. A friend worked there and…